Pilot Study for the Validity of a Content-based Information Provision Tool Aimed at Improving the Hospitalization Experience of Liver Transplant Patients

Liver Transplantation Clinical Trial

Official title:

Pilot Study for the Validity of a Content-based Information Provision Tool Aimed at Improving the Hospitalization Experience of Liver Transplant Patients

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06424808
• Other study ID #: 2024-04-078-001
• Status: Not yet recruiting
• Phase: N/A
• Start date: May 21, 2024
• Est. completion date: November 30, 2024

Study information

• Verified date: May 2024
• Source: Samsung Medical Center
• Contact: Su Min Kim, Ph.D
• Phone: 821020340550
• Email: flyhighsoom[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The investigators aim to evaluate the improvement of the inpatient experience and the usability of a content-based tool (a brochure). This involves consolidating video content for inpatients on a single website and providing access to it via QR codes in a brochure format. [Patients] Considering this as a pilot study, the investigators plan to recruit around 30 participants. Both the experimental and control groups will receive standard care and information, with the experimental group additionally receiving the brochure. Random assignment will be used for the experimental and control groups. Surveys and interviews will be conducted to assess changes in patient experience and usability before and after providing the brochure. [Medical Staff] Among the medical staff involved in the liver transplant surgical process, researchers will select participants based on their degree of involvement with the intervention subjects. After obtaining their consent, interviews will be conducted concerning patient experiences and the brochure.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 40
• Est. completion date: November 30, 2024
• Est. primary completion date: October 31, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

[Patients]

• Adults aged 18 and over
• Patients who are scheduled to undergo or have undergone liver transplant surgery
• Recruited through a call for research participants and have consented to participate in this study [Medical Staff]
• Adults aged 18 and over
• Medical staff at Samsung Medical Center involved in the post-liver transplant treatment process Exclusion Criteria: [Patients]
• Individuals who have not consented to participate in this study
• Individuals whose health condition makes it difficult to participate in the intervention
• During the research period, the researcher will check if the brochure content has been shared during surveys or interviews with the research participants (information dissemination). If information dissemination is confirmed, the participant will be excluded from the study. [Medical Staff]
• Individuals who have not consented to participate in this study
• Medical staff not involved in the liver transplant treatment process

Related Conditions & MeSH terms

• Inpatients
• Liver Transplantation

Intervention

Other:
• Consolidating content on a single website and providing access to it via QR codes in a brochure format
The group assigned to the experimental group will receive information in the same manner as current patients do, with the addition of receiving a brochure once when moving to a general ward after surgery. Afterward, they are free to use the brochure. The control group will receive information only in the manner currently provided to patients.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Samsung Medical Center

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Inpatient Experience 1	Inpatient Experience Evaluation Score, which ranges from a minimum of 0 to a maximum of 100 points, with higher scores indicating better patient experiences.	During the intervention
Primary	Inpatient Experience 2	Analysis of survey response trends and frequencies between the experimental and control groups	During the intervention
Primary	Inpatient Experience 3	Qualitative research through interviews	Patient: During the intervention and after intervention(Two times)/Medical staff: During the study period
Secondary	Informational value of the intervention tool	Asking informational value of the intervention tool from survey and interview	During the intervention
Secondary	Usability value of the intervention tool	Survey uses 'System Usability Scail' which ranges a minimum of 0 to a maximum of 100 points, with higher scores indicating better usability. Also related question will be asked by intervew.	During the intervention
Secondary	Regarding utilization of the intervention tool	A survey and interview on the experience of utilization during hospitalization	During the intervention
Secondary	Areas for improvement	A survey and interview on the advice for improvement	During the intervention